Dow Down 1.10% Nasdaq Down 1.82%

More On GENE

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Genetic Technologies Limited (GENE)

-NasdaqCM
2.05 Down 0.06(2.89%) Feb 8, 3:56PM EST
Prev Close:2.11
Open:2.07
Bid:1.61 x 1000
Ask:2.26 x 500
1y Target Est:12.50
Beta:2.08172
Next Earnings Date:N/A
Day's Range:2.02 - 2.14
52wk Range:1.62 - 11.00
Volume:60,856
Avg Vol (3m):574,566
Market Cap:23.43M
P/E (ttm):N/A
EPS (ttm):-0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GENE

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genetic Technologies Limited operates as a molecular diagnostics company that offers predictive testing and assessment tools to help physicians in managing women’s health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback